Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/41834
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorAMARAL, Carolina Maranhao Meneghel
dc.contributor.authorCARVALHO, Renata Cunha
dc.contributor.authorVIEIRA, Marcio Eduardo Bergamini
dc.contributor.authorAGUIAR, Patricia Melo
dc.date.accessioned2021-08-13T15:29:52Z-
dc.date.available2021-08-13T15:29:52Z-
dc.date.issued2021
dc.identifier.citationAMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION, v.85, n.6, article ID 8285, 10p, 2021
dc.identifier.issn0002-9459
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/41834-
dc.description.abstractObjective. To map undergraduate pharmacy students' use of medications for anxiety and depression and associated factors at one university in Brazil. Methods. A cross-sectional study was conducted from May to July 2019 among undergraduate pharmacy students at one university. Data regarding sociodemographic issues and the use of psychotropics were collected using an online questionnaire. Exploratory descriptive analysis of data, the chi-square test, and multivariate binary logistic regression were performed to identify factors associated with the use of medications for anxiety and depression. Results. Of 900 students enrolled, usable survey responses were received from 198. Most respondents were female with a mean age of 22.3 years. Among these, 17.7% of pharmacy students used medications to treat anxiety and 13.1% used medications for depression. The most common psychotropics were escitalopram and fluoxetine. There were two peak usage times: the initial and final year of pharmacy school. Dissatisfaction with the pharmacy program and psychological care were significantly associated with the use of medications for anxiety. In contrast, monthly income from three to 15 times the minimum wage, religiosity/spirituality, and psychological care were associated with students' use of medications for depression. Conclusion. There was a high prevalence of medication use to treat anxiety and depression among undergraduate pharmacy students, and this use was associated with psychological care, monthly income, and religiosity/spirituality.eng
dc.language.isoeng
dc.publisherAMER ASSOC COLL PHARMACYeng
dc.relation.ispartofAmerican Journal of Pharmaceutical Education
dc.rightsopenAccesseng
dc.subjectdepressioneng
dc.subjectanxietyeng
dc.subjectpharmacy studentseng
dc.subjectprevalenceeng
dc.subjectpsychotropiceng
dc.subject.otheruniversity-studentseng
dc.subject.othermental-healtheng
dc.subject.othersocial determinantseng
dc.subject.otherspiritualityeng
dc.subject.otherprevalenceeng
dc.subject.otherreligioneng
dc.subject.othercollegeeng
dc.titleFactors Associated With Use of Medications for Anxiety and Depression in Pharmacy Students in Brazileng
dc.typearticleeng
dc.rights.holderCopyright AMER ASSOC COLL PHARMACYeng
dc.identifier.doi10.5688/ajpe8285
dc.identifier.pmid34315701
dc.subject.wosEducation, Scientific Disciplineseng
dc.subject.wosPharmacology & Pharmacyeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
hcfmusp.author.externalAMARAL, Carolina Maranhao Meneghel:Univ Sao Paulo, Fac Pharmaceut Sci, Av Prof Lineu Prestes 580,Bloco 13,Cidade Univ, Butana, SP, Brazil
hcfmusp.author.externalAGUIAR, Patricia Melo:Univ Sao Paulo, Fac Pharmaceut Sci, Av Prof Lineu Prestes 580,Bloco 13,Cidade Univ, Butana, SP, Brazil
hcfmusp.description.articlenumber8285
hcfmusp.description.issue6
hcfmusp.description.volume85
hcfmusp.origemWOS
hcfmusp.origem.idWOS:000678424200008
hcfmusp.origem.id2-s2.0-85111979922
hcfmusp.publisher.cityALEXANDRIAeng
hcfmusp.publisher.countryUSAeng
hcfmusp.relation.referenceAllen J, 2014, INT REV PSYCHIATR, V26, P392, DOI 10.3109/09540261.2014.928270eng
hcfmusp.relation.referenceAmerican College Health Association, 2019, AM COLL HLTH ASS NATeng
hcfmusp.relation.referenceAmerican Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th ed., DOI 10.1176/appi.books.9780890425596eng
hcfmusp.relation.referenceAmerican Psychological Association, 2019, APA GUID TREATM DEPR APA GUID TREATM DEPReng
hcfmusp.relation.referenceAndrews G, 2018, AUST NZ J PSYCHIAT, V52, P1109, DOI 10.1177/0004867418799453eng
hcfmusp.relation.referenceBalayssac D, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00725eng
hcfmusp.relation.referenceBayram N, 2008, SOC PSYCH PSYCH EPID, V43, P667, DOI 10.1007/s00127-008-0345-xeng
hcfmusp.relation.referenceCabrita J, 2004, PHARM WORLD SCI, V26, P79, DOI 10.1023/B:PHAR.0000018597.46246.34eng
hcfmusp.relation.referencede Oliveira LB, 2019, REV ASSOC MED BRAS, V65, P870, DOI 10.1590/1806-9282.65.6.870eng
hcfmusp.relation.referenceDein S, 2010, PSYCHIATR BULL, V34, P63, DOI 10.1192/pb.bp.109.025924eng
hcfmusp.relation.referenceFernandes CSE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207921eng
hcfmusp.relation.referenceFarrer LM, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0961-zeng
hcfmusp.relation.referenceFischbein R, 2019, AM J PHARM EDUC, V83, P2204, DOI 10.5688/ajpe7558eng
hcfmusp.relation.referenceGotzsche PC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2435eng
hcfmusp.relation.referenceHall W, 2019, J HUMANIST PSYCHOL, V59, P720, DOI 10.1177/0022167818765331eng
hcfmusp.relation.referenceIbrahim AK, 2013, J PSYCHIATR RES, V47, P391, DOI 10.1016/j.jpsychires.2012.11.015eng
hcfmusp.relation.referenceIp EJ, 2016, AM J PHARM EDUC, V80eng
hcfmusp.relation.referenceIstilli PT., 2010, REV LAT-AM ENFERM, V18, P131eng
hcfmusp.relation.referenceJanuary J, 2018, SYST REV-LONDON, V7, DOI 10.1186/s13643-018-0723-8eng
hcfmusp.relation.referenceJobst A, 2016, EUR PSYCHIAT, V33, P18, DOI 10.1016/j.eurpsy.2015.12.003eng
hcfmusp.relation.referenceKelly D, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-046054eng
hcfmusp.relation.referenceLipson SK, 2018, J MENT HEALTH, V27, P205, DOI 10.1080/09638237.2017.1417567eng
hcfmusp.relation.referenceLopes JMN., 2019, BRAZ J PHARM SCI, P151eng
hcfmusp.relation.referenceMacaskill A, 2013, BRIT J GUID COUNS, V41, P426, DOI 10.1080/03069885.2012.743110eng
hcfmusp.relation.referenceMarchi KC, 2013, REV ELETRONICA ENFER REV ELETRONICA ENFER, V15, P731eng
hcfmusp.relation.referenceMayer FB, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0791-1eng
hcfmusp.relation.referenceMcKenzie SK, 2018, AM J MENS HEALTH, V12, P1247, DOI 10.1177/1557988318772732eng
hcfmusp.relation.referenceMishra SK, 2017, J RELIG HEALTH, V56, P1282, DOI 10.1007/s10943-015-0100-zeng
hcfmusp.relation.referenceMoreira-Almeida A, 2014, REV BRAS PSIQUIATR, V36, P176, DOI 10.1590/1516-4446-2013-1255eng
hcfmusp.relation.referenceNational Institute for Health and Care Excellence (NICE), 2011, GEN ANX DIS PAN DIS GEN ANX DIS PAN DISeng
hcfmusp.relation.referenceNevill A, 2004, J FURTH HIGH ED, V28, P179eng
hcfmusp.relation.referenceRibeiro AG, 2014, CIENC SAUDE COLETIVA, V19, P1825, DOI 10.1590/1413-81232014196.06332013eng
hcfmusp.relation.referenceRotenstein LS, 2016, JAMA-J AM MED ASSOC, V316, P2214, DOI 10.1001/jama.2016.17324eng
hcfmusp.relation.referenceSaeed H, 2018, INT J MENT HEALTH AD, V16, P1283, DOI 10.1007/s11469-017-9859-3eng
hcfmusp.relation.referenceSantisi G, 2018, PSYCHOL RES BEHAV MA, V11, P187, DOI 10.2147/PRBM.S164745eng
hcfmusp.relation.referenceSeidler ZE, 2017, J MENS STUD, V26, P92, DOI 10.1177/1060826517729406eng
hcfmusp.relation.referenceShamsuddin K, 2013, ASIAN J PSYCHIATR, V6, P318, DOI 10.1016/j.ajp.2013.01.014eng
hcfmusp.relation.referenceSilva M, 2016, EUR J PSYCHIAT, V30, P259eng
hcfmusp.relation.referenceSoldera M, 2004, REV SAUDE PUBL, V38, P277, DOI 10.1590/S0034-89102004000200018eng
hcfmusp.relation.referenceStallman HM, 2010, AUST PSYCHOL, V45, P249, DOI 10.1080/00050067.2010.482109eng
hcfmusp.relation.referenceSteptoe A, 2007, INT J BEHAV MED, V14, P97, DOI 10.1007/BF03004175eng
hcfmusp.relation.referenceTabalipa Fábio de Oliveira, 2015, Rev. bras. educ. med., V39, P388, DOI 10.1590/1981-52712015v39n3e02662014eng
hcfmusp.relation.referenceTeh CK, 2015, OPEN J EPIDEMIOL, V5, P260eng
hcfmusp.relation.referenceTempski P, 2012, BMC MED EDUC, V12, DOI 10.1186/1472-6920-12-106eng
hcfmusp.relation.referenceVandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1eng
hcfmusp.relation.referenceVasconcelos Tatheane Couto de, 2015, Rev. bras. educ. med., V39, P135, DOI 10.1590/1981-52712015v39n1e00042014eng
hcfmusp.relation.referenceWeber SR, 2014, CURR OPIN PSYCHIATR, V27, P358, DOI 10.1097/YCO.0000000000000080eng
hcfmusp.relation.referenceWorld Health Organisation (WHO), 2015, MENT HLTH ACT PLAN 2eng
hcfmusp.relation.referenceWorld Health Organization, 2017, DEPRESSION OTHER COMeng
hcfmusp.relation.referenceWorld Health Organization and Calouste Gulbenkian Foundation, 2014, SOCIAL DETERMINANTSeng
dc.description.indexMEDLINEeng
dc.identifier.eissn1553-6467
hcfmusp.citation.scopus0-
hcfmusp.scopus.lastupdate2022-11-24-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - HU
Hospital Universitário - HU

Artigos e Materiais de Revistas Científicas - ODS/08
ODS/08 - Trabalho decente e crescimento econômico

Artigos e Materiais de Revistas Científicas - ODS/10
ODS/10 - Redução da desigualdade


Files in This Item:
File Description SizeFormat 
art_AMARAL_Factors_Associated_With_Use_of_Medications_for_Anxiety_2021.PDFpublishedVersion (English)545.48 kBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.